Sage Journals: Discover world-class research

Abstract

Hepatitis C (HC) has been recently diagnosed by determination of specific antibodies that represent the former so-called non-A, non-B hepatitis.

We studied the prevalence of plasma HCV antibodies among 61 unselected patients on hemodialysis (HD) and 43 on continuous ambulatory peritoneal dialysis (CAPD). Plasma C-antibodies were determined through the ELISA test system. Transfusion policy was the same in both groups.

The prevalence of hepatitis C virus antibodies was significantly higher in hemodialysis patients than among those on CAPD. Time on dialysis, previous blood transfusions, and renal transplantation seem to increase the prevalence of C hepatitis antibodies among hemodialy sis patients. The effect of these parameters on CAPD was smaller. Understanding the reasons for these differences may help prevent this disease among dialysis patients.

Keywords

Hepatitis C non-A non-B hepatitis dialysis-associated hepatitis

Get full access to this article

View all access options for this article.

References

Kuo

, Choo

Q.L.

, Alter

H.J.

An assayforcirculating antibodies to a major etiologic virus of human nonA, non-B hepatitis.

Science 1989; 244: 362–4.

Alter

H.J.

, Purcell

R.H.

, Shih

J.W.

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-E hepatitis.

N Engl J Med 1989; 321: 1494–500.

Alter

M.J.

, Sampliner

R.E.

Hepatitis C and miles to go before we sleep.

N Engl J Med 1989; 321: 1538–9.

Esteban

J.I.

, Viladomiu

, Gonzalez

Hepatitis C virus antibodies among risk groups in Spain.

Lancet 1989; 5: 294–7.

Van der Poel

C.L.

, Lelie

P.N.

, Choo

Q.L.

Antihepatitis C antibodies and non-A, non-B post-transfusionhepatitis in the Netherlands.

Lancet. 1989; 5: 297–9.

Dienstag

J.L.

Non-A, non-E hepatitis. I. Recognition, epidemiology and clinical features.

Gastroenterology 1989; 85: 439–62.

Alter

H.J.

Chronic consequences of non-A, non-Bhepatitis. In: Seeff

L.B.

, Lewis

J.H.

, eds. Current perspectives in hepatology. New York: Plenum Medical, 1989: 8397.

Crosnier

, Degos

, Jungers

Dialysis -associated hepatitis. In: Maher

J.F.

, ed. Replacement of renal function by dialysis. Dordrecht: Kluwer Academic Publishers, 1989: 881–903.

Eschbach

J.W.

Hematological problems of dialysis patients. In: Maher

J.R.

, ed. Replacement of renal function by dialysis. Dordrecht: Kluwer Academic Publishers, 1989: 851–64.

10.

Jeffers

L.J.

, Perez

G.O.

, De Medina

M.D.

Hepatitis C infection in two urban hemodialysis units.

Kidney Int 1990; 38: 320–2.

11.

Jadael

, Cornu

, Lamy

M.E.

Prevalence and clinical significance of hepatitis C virus antibodies in hemodialysis patients.

Nephrol Dial Transplant 1990; 5: 705.

12.

Kallinowski

, Theilman

, Gmeliln

Prevalence of hepatitis C virus antibodies in hemodialysis and kidney transplant patients.

Nephrol Dial Transplant 1990; 5: 706.

13.

Susanna

, Tagriello

, Gaio

Hepatitis C virus prevalence and transmission in patients on regular dialytic treatment.

Nephrol Dial Transplant 1990; 5: 714.

14.

Terue

J.L.

, Marcen

, Gomez

Antibodies to hepatitis C virus in patients in hemodialysis and after kidney transplantation.

Nephrol Dial Transplant 1990; 5: 714.

Prevalence of Hepatitis c Antibodies (HCV) in a Dialysis Population at One Center

Abstract

Keywords

Get full access to this article

References